Sinovac (Dalian) Vaccine Technology Co., Ltd.
20
1
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 20 trials
100.0%
+13.5% vs industry average
85%
17 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Second Dose of Varicella Vaccine in Healthy Children
Role: lead
Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial
Role: lead
Study on Booster Immunization With Varicella Vaccine at Different Intervals
Role: lead
Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)
Role: lead
Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine
Role: lead
Correlation of Protection Against Varicella in an Exploratory Study
Role: lead
Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines
Role: lead
An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine
Role: lead
An Immunity Persistence Study of Live Attenuated Varicella Vaccine
Role: lead
Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old
Role: lead
Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province
Role: lead
Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus
Role: lead
A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A Vaccine
Role: lead
An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization
Role: lead
Safety Study of Live Attenuated Mumps Vaccines in Junior High School Students Under 14 Years Old
Role: lead
Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine
Role: lead
A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine
Role: lead
A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines
Role: lead
Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
Role: lead
A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children
Role: lead
All 20 trials loaded